Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation

H. C. Schouten; J. O. Armitage; L. W. Klassen; W. P. Vaughan; P. J. Bierman; D. Weisenburger; A. Kessinger

Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation

H. C. Schouten, J. O. Armitage, L. W. Klassen, W. P. Vaughan, P. J. Bierman, D. Weisenburger, A. Kessinger

Research output: Contribution to journal › Article › peer-review

Abstract

Two patients who underwent autologous bone marrow transplantation for recurrent non-Hodgkin's lymphoma relapsed at 46 and 28 days after the transplant. Both patients had an HLA-identical sibling and were treated with high-dose chemotherapy and allogeneic marrow transplantation. One patient is now 24 months after the allogeneic transplant without evidence of disease. The second patient died on day 7 with interstitial pneumonia. We conclude that high-dose therapy and allogeneic bone marrow transplantation after failure of autologous transplantation for non-Hodgkin's lymphoma is feasible and should be considered in young patients with HLA-identical siblings.

Original language	English (US)
Pages (from-to)	119-121
Number of pages	3
Journal	Bone marrow transplantation
Volume	4
Issue number	1
State	Published - 1989

ASJC Scopus subject areas

Hematology
Transplantation

Cite this

@article{0ad2853a439b48b5a8f3a9de5f1b24cc,

title = "Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation",

abstract = "Two patients who underwent autologous bone marrow transplantation for recurrent non-Hodgkin's lymphoma relapsed at 46 and 28 days after the transplant. Both patients had an HLA-identical sibling and were treated with high-dose chemotherapy and allogeneic marrow transplantation. One patient is now 24 months after the allogeneic transplant without evidence of disease. The second patient died on day 7 with interstitial pneumonia. We conclude that high-dose therapy and allogeneic bone marrow transplantation after failure of autologous transplantation for non-Hodgkin's lymphoma is feasible and should be considered in young patients with HLA-identical siblings.",

author = "Schouten, {H. C.} and Armitage, {J. O.} and Klassen, {L. W.} and Vaughan, {W. P.} and Bierman, {P. J.} and D. Weisenburger and A. Kessinger",

year = "1989",

language = "English (US)",

volume = "4",

pages = "119--121",

journal = "Bone marrow transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation

AU - Schouten, H. C.

AU - Armitage, J. O.

AU - Klassen, L. W.

AU - Vaughan, W. P.

AU - Bierman, P. J.

AU - Weisenburger, D.

AU - Kessinger, A.

PY - 1989

Y1 - 1989

N2 - Two patients who underwent autologous bone marrow transplantation for recurrent non-Hodgkin's lymphoma relapsed at 46 and 28 days after the transplant. Both patients had an HLA-identical sibling and were treated with high-dose chemotherapy and allogeneic marrow transplantation. One patient is now 24 months after the allogeneic transplant without evidence of disease. The second patient died on day 7 with interstitial pneumonia. We conclude that high-dose therapy and allogeneic bone marrow transplantation after failure of autologous transplantation for non-Hodgkin's lymphoma is feasible and should be considered in young patients with HLA-identical siblings.

AB - Two patients who underwent autologous bone marrow transplantation for recurrent non-Hodgkin's lymphoma relapsed at 46 and 28 days after the transplant. Both patients had an HLA-identical sibling and were treated with high-dose chemotherapy and allogeneic marrow transplantation. One patient is now 24 months after the allogeneic transplant without evidence of disease. The second patient died on day 7 with interstitial pneumonia. We conclude that high-dose therapy and allogeneic bone marrow transplantation after failure of autologous transplantation for non-Hodgkin's lymphoma is feasible and should be considered in young patients with HLA-identical siblings.

UR - http://www.scopus.com/inward/record.url?scp=0024505146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024505146&partnerID=8YFLogxK

M3 - Article

C2 - 2466510

AN - SCOPUS:0024505146

SN - 0268-3369

VL - 4

SP - 119

EP - 121

JO - Bone marrow transplantation

JF - Bone marrow transplantation

IS - 1

ER -

Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this